BIO-Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

AstraZeneca at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

AstraZeneca takes part in 2 sessions at BIO-Europe 2026 in Cologne. Its sessions cover clinical trial systems and how biopharma partnerships can become greener.

OrganizationBIO-Europe 2026 Attendance
AstraZeneca
Cambridge, United Kingdom
Large pharma
Global pharmaceutical company developing medicines in oncology, cardiovascular, renal, respiratory, immunology and rare diseases.
Panel
Tue Nov 10
16:00–16:45
Unlocking Clinical Trial Systems
How EU clinical trial rules and a planned EU biotech law affect trial approval times, and whether Europe can speed up safely.
with R Kupiec Consulting, Parexel, Merck KGaA
Panel
Wed Nov 11
09:00–09:30
Sustainability & Innovation: Transforming Biopharma Partnerships for a Greener Future
How drug companies, smaller firms and suppliers can team up to cut supply chain carbon emissions and bring greener technologies to industrial scale.

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at AstraZeneca

Tell us what you sell and we’ll find the people at AstraZeneca most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction